Overexpression of interleukin-13 in a murine T-cell lymphoma: a possible factor of DL-induced immunosuppression and tumor progression

Cancer Invest. 2009 Jul;27(6):641-9. doi: 10.1080/07357900802622758.

Abstract

Interleukin-13 (IL-13) is a T(H)2 cytokine that plays a crucial role in the pathophysiology of tumors and favor tumor growth and recurrence by negative regulation of tumor immunosurveillance. In the present investigation, we have determined the IL-13 level in the serum and ascitic fluid of the DL-bearing host and the possible source of IL-13 in the ascitic fluid. IL-13 level was elevated in serum and ascitic fluid of host bearing a transplantable T-cell lymphoma. DL cells as well as tumor-associated macrophages express and secrete IL-13 in the milieu, which provide further insight for DL-induced immunosuppression in a tumor-bearing host.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ascites / immunology*
  • Cell Line, Tumor
  • Female
  • Gene Expression Regulation, Neoplastic
  • Immune Tolerance*
  • Interleukin-13 / blood
  • Interleukin-13 / genetics
  • Interleukin-13 / metabolism*
  • Lymphoma, T-Cell / genetics
  • Lymphoma, T-Cell / immunology*
  • Lymphoma, T-Cell / pathology
  • Macrophages / immunology
  • Mice
  • Mice, Inbred BALB C
  • RNA, Messenger / metabolism
  • Time Factors
  • Tumor Escape*
  • Up-Regulation

Substances

  • Interleukin-13
  • RNA, Messenger